3652 results for «231»

Filter By

3652 results

Imaging for mitral valve interventions

28 Nov 2022 – From PCR London Valves 2022

Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.

Imaging for mitral valve interventions

Secondary mitral regurgitation: challenges in management

28 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.

Secondary mitral regurgitation: challenges in management

How should I treat a patient with multivessel disease - A patient's journey

04 Mar 2023 – From AfricaPCR 2023

In this session, study the case of a 55-year-old female patient with DM and previous inferior STEMI, who presented with minimal exertion angina, 48% EF and mild MR, and follow her journey to understand how to optimally handle the specifics of patients with multivessel disease.

How should I treat a patient with multivessel disease - A patient's journey

Transcatheter tricuspid valve interventions: outcomes

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentations to learn how to better assess transcatheter tricuspid valve interventions results, to understand what are the endpoints after interventions as well as to learn what we can expect in future guidelines.

Transcatheter tricuspid valve interventions: outcomes

Multiple VHD: a diagnostic and clinical challenge

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult these presentations on multiple VHD to learn how to deal with combined valvular lesions, how to assess their severity and how to treat them.

Multiple VHD: a diagnostic and clinical challenge

Imaging before and after TAVI - How to treat

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.

Imaging before and after TAVI - How to treat

Where are we going? The symptomatic patient with moderate aortic stenosis

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.

Where are we going? The symptomatic patient with moderate aortic stenosis

Diagnosis of disease type and of disease severity

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.

Diagnosis of disease type and of disease severity

PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.

Join us in Tokyo from 13-15 February: Explore the Toranomon Hills Tower venue and stay updated on the best deals for flights and hotel accommodations.

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

20 May 2026

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG
Didn’t find what you were looking for?